PATENT CLAIM ANALYSIS

Application Number: 15755752
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-02
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides an ACVR1-Fc fusion protein, a nucleic acid sequence encoding said fusion protein, a vector or a host cell comprising said encoding sequence, a method for producing said fusion protein, and use of any of the above in prevention and/or treatment of diseases or conditions associated with ACVR1 abnormality (e.g. ACVR1 mutation and/or over-activation).

Claim (Index 21):
The method of  claim 20 , wherein the disease or condition is selected from at least one of the group consisting of:\n ossification or pleonosteosis associated diseases; and at least one of the group consisting of cancers and over-activation associated with ACVR1, the at least one of the group consisting of cancers and over-activation associated with ACVR1 being at least one of:\n high-grade gliomas, such as diffuse endogenous pontine gliomas; and \n ovarian cancer.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 99.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15300088', '14521143', '13654208', '12296275', '11716794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047846882154013
- 35 USC 102 Novelty (BERT): 0.5289085033431915
- Combined Prediction Score: 0.7771970697281804
- Mean Citation Score: 330.693196
- Max Citation Score: 359.5958
- Similarity Product: 240.5315562266946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test